Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Malignant Lymphoma

  Free Subscription


23.05.2022

1 Am J Hematol
3 Am J Surg Pathol
3 Blood
2 Br J Haematol
3 Haematologica
4 J Am Acad Dermatol
1 J Virol
2 Leuk Lymphoma
1 Leukemia
1 Mod Pathol
3 N Engl J Med
2 Oncology (Williston Park)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. SAUL EE, Alderuccio JP, Reis IM, Zhao W, et al
    Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma.
    Am J Hematol. 2022 May 12. doi: 10.1002/ajh.26591.
    PubMed         Abstract available


    Am J Surg Pathol

  2. EL HUSSEIN S, Wang X, Fang H, Jelloul FZ, et al
    Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.
    Am J Surg Pathol. 2022 May 16. pii: 00000478-990000000-00024.
    PubMed         Abstract available

  3. HANG JF, Yuan CT, Chang KC, Wang RC, et al
    Targeted Next-generation Sequencing Reveals a Wide Morphologic and Immunophenotypic Spectrum of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma.
    Am J Surg Pathol. 2022 May 12. pii: 00000478-990000000-00022.
    PubMed         Abstract available

  4. LAURENT C, Syrykh C, Hamon M, Adelaide J, et al
    Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation.
    Am J Surg Pathol. 2022;46:742-753.
    PubMed         Abstract available


    Blood

  5. CERHAN JR
    A (modifiable) way to better Hodgkin lymphoma survivorship?
    Blood. 2022;139:3004-3005.
    PubMed        

  6. CALABRETTA E, Hamadani M, Carlo-Stella C
    THE ANTIBODY-DRUG CONJUGATE LONCASTUXIMAB TESIRINE FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA.
    Blood. 2022 May 17. pii: 485279. doi: 10.1182/blood.2021014663.
    PubMed         Abstract available

  7. ALI A, Goy A, Dunleavy K
    CAR T-cell Therapy in Highly-Aggressive B-Cell Lymphoma: Emerging Biological and Clinical Insights.
    Blood. 2022 May 13. pii: 485238. doi: 10.1182/blood.2022016226.
    PubMed         Abstract available


    Br J Haematol

  8. DAWUDI Y, Benali K, Beydon M, Hourseau M, et al
    B-cell lymphoma mimicking relapsing polychondritis.
    Br J Haematol. 2022 May 20. doi: 10.1111/bjh.18220.
    PubMed        

  9. ZHU K, Jamroz A, Huang S, Villa D, et al
    Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia.
    Br J Haematol. 2022 May 14. doi: 10.1111/bjh.18241.
    PubMed         Abstract available


    Haematologica

  10. SARKOZY C, Salles G
    PET-CT before autologous stem cell transplant in follicular lymphoma: coming too late?
    Haematologica. 2022 May 19. doi: 10.3324/haematol.2021.281255.
    PubMed         Abstract available

  11. EYRE TA, Barrington SF, Okosun J, Abamba C, et al
    Impact of PET-CT status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplant.
    Haematologica. 2022 May 19. doi: 10.3324/haematol.2021.280287.
    PubMed         Abstract available

  12. RIGAUD C, Abbou S, Ducassou S, Simonin M, et al
    Profound and sustained response with next generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement.
    Haematologica. 2022 May 19. doi: 10.3324/haematol.2021.280081.
    PubMed         Abstract available


    J Am Acad Dermatol

  13. CHOI J, Sutaria N, Roh YS, Bordeaux Z, et al
    Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: A cross-sectional analysis of the 2012-2017 National Inpatient Sample.
    J Am Acad Dermatol. 2022;86:1408-1410.
    PubMed        

  14. SUH KS, Jang MS, Jung JH, Kwon DI, et al
    Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review.
    J Am Acad Dermatol. 2022;86:1275-1284.
    PubMed         Abstract available

  15. O'DONNELL M, Zaya R, Correia E, Krishnasamy S, et al
    Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: A single-center retrospective study.
    J Am Acad Dermatol. 2022;86:1285-1292.
    PubMed         Abstract available

  16. JUNG JM, Yoo H, Lim DJ, Won CH, et al
    Clinicoprognostic implications of head and neck involvement by mycosis fungoides: A retrospective cohort study.
    J Am Acad Dermatol. 2022;86:1258-1265.
    PubMed         Abstract available


    J Virol

  17. CHASSEUR AS, Trozzi G, Istasse C, Petit A, et al
    Marek's Disease Virus Virulence Genes Encode Circular RNAs.
    J Virol. 2022;96:e0032122.
    PubMed         Abstract available


    Leuk Lymphoma

  18. STRUSSMANN T, Wasch R, Scherer F, Mutter JA, et al
    A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin.
    Leuk Lymphoma. 2022 May 20:1-3. doi: 10.1080/10428194.2022.2074991.
    PubMed        

  19. GORDON MJ, Sureda A, Westin JR
    Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era in aggressive lymphoma.
    Leuk Lymphoma. 2022 May 12:1-11. doi: 10.1080/10428194.2022.2068007.
    PubMed         Abstract available


    Leukemia

  20. FERRERI AJM, Cwynarski K, Pulczynski E, Fox CP, et al
    Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
    Leukemia. 2022 May 13. pii: 10.1038/s41375-022-01582.
    PubMed         Abstract available


    Mod Pathol

  21. GISRIEL SD, Yuan J, Braunberger RC, Maracaja DLV, et al
    Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.
    Mod Pathol. 2022 May 13. pii: 10.1038/s41379-022-01091.
    PubMed         Abstract available


    N Engl J Med

  22. HENRY B, Buffet P, Bates I
    Marginal-Zone Lymphomas.
    N Engl J Med. 2022;386:1962.
    PubMed        

  23. MATUCHANSKY C
    Marginal-Zone Lymphomas.
    N Engl J Med. 2022;386:1962.
    PubMed        

  24. BERTONI F, Rossi D, Zucca E
    Marginal-Zone Lymphomas. Reply.
    N Engl J Med. 2022;386:1962-1963.
    PubMed        


    Oncology (Williston Park)

  25. STUVER R, Epstein-Peterson ZD, Johnson WT, Khan N, et al
    Current Treatment of Peripheral T-cell Lymphoma.
    Oncology (Williston Park). 2022;36:293-305.
    PubMed         Abstract available

  26. NASTA SD
    Making Progress in PTCL: Significant Unmet Needs.
    Oncology (Williston Park). 2022;36:296.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: